Clinical Trial Update: Exemestane in Combination With Fulvestrant in Postmenopausal Women With Hormone Sensitive Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the combination of exemestane and fulvestrant in postmenopausal women with hormone-sensitive advanced breast cancer has completed and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Aromasin (exemestane)
• Faslodex (fulvestrant)

Snippet

Sponsor: Ohio State University Comprehensive Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-08-15